Go Back
IGM Biosciences, Inc. reports $59.3 million Q1 loss
By USInMinutes - May 12, 2023, 10:38 AM ET
Last Updated - Jul 18, 2023, 03:29 PM EDT
The company generated $0.52 million in quarterly revenue
IGM Biosciences, Inc. [IGMS] has reported fiscal Q1 loss of $59.30 million.
On a per-share basis, the DE based company said its diluted earnings are $1.33.
The Pharmaceutical Preparations firm posted revenue of $0.52 million in this period.
Also Read:
- IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at Two Upcoming Investor Conferences
- IGM Biosciences to Present at the Stifel 2023 Targeted Oncology Days
- IGM Biosciences Announces Six Presentations at the American Society for Cancer Research Annual ...
- IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and ...
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News